文献速递慢病管理老年与多病共存

复杂多病共存与简单多病共存患者的治疗负担差异:日本全国横断面研究

Treatment burden in complex versus simple multimorbidity: nationwide cross-sectional study in Japan.
PubMed 文献 · Fam Pract · 2026-01-01

该研究基于日本全国成人横断面调查(1341名参与者),评估复杂多病共存(3种及以上长期疾病且累及至少3个不同身体系统)与简单多病共存患者的治疗负担差异。结果显示,调整混杂因素后,复杂多病共存患者高治疗负担的患病率比是简单多病共存患者的1.47倍(95%CI:1.14-1.90)。结论支持将复杂多病共存作为识别高医疗需求患者的概念区分。

要点

  • 复杂多病共存患者高治疗负担风险显著高于简单多病共存患者(调整后PR=1.47)。
  • 复杂多病共存患病率随年龄增长呈上升趋势。
  • 识别复杂多病共存亚组有助于制定减轻治疗负担的策略。

核心结论

  • 在具有全国代表性的日本成人样本中,复杂多病共存患者比简单多病共存患者经历更高的治疗负担。
  • 研究结果支持将复杂多病共存作为识别复杂医疗需求患者的概念区分。
  • 识别这些亚组并实施减轻治疗负担的策略可能有助于改善多病共存患者的健康结局。

研究设计与样本

  • 研究为日本全国成人横断面调查。
  • 共纳入1341名参与者,其中384人(28.6%)有多病共存,130人(9.7%)有复杂多病共存。
  • 主要结局为高治疗负担,采用日本版多病共存治疗负担问卷(MTBQ)评估。
  • 使用多变量修正泊松回归分析调整可能的混杂因素。

主要发现

  • 复杂多病共存的存在随年龄增长呈增加趋势。
  • 调整混杂因素后,与简单多病共存相比,复杂多病共存与高治疗负担增加相关(调整患病率比=1.47,95%CI:1.14-1.90)。

关键数值与推荐

  • 复杂多病共存定义为3种及以上长期疾病共存且累及至少3个不同身体系统。
  • 高治疗负担由日本版MTBQ评估。

临床怎么用

  • 全科医生可识别复杂多病共存患者(3种及以上长期疾病且累及至少3个身体系统)以评估其治疗负担。
  • 对复杂多病共存患者应考虑实施减轻治疗负担的策略以改善健康结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The concept of "complex multimorbidity", defined as the coexistence of three or more long-term conditions affecting at least three different body systems, has recently emerged in medical literature. However, it remains unclear whether this concept effectively identifies patients with greater complexity of care needs. OBJECTIVE: We aimed to evaluate how treatment burden differs between complex and simple multimorbidity. METHODS: We conducted a nationwide cross-sectional survey of the Japanese adult population. The primary outcome measure was high treatment burden, as assessed by the Japanese version of the Multimorbidity Treatment Burden Questionnaire (MTBQ). We used a multivariable modified Poisson regression analysis to adjust for possible confounders. RESULTS: Of the 1341 participants, 384 (28.6%) had multimorbidity, and 130 (9.7%) had complex multimorbidity. The presence of complex multimorbidity tended to increase with age. After adjusting for possible confounders, complex multimorbidity was associated with an increase in high treatment burden, compared with simple multimorbidity (adjusted prevalence ratio = 1.47, 95% CI: 1.14-1.90). CONCLUSION: Patients with complex multimorbidity experienced a higher treatment burden than those with simple multimorbidity in a nationally representative sample of Japanese adults. These findings support the conceptual distinction of complex multimorbidity for identifying patients with complex healthcare needs. Recognizing these subgroups and implementing strategies to reduce treatment burden may contribute to improved health outcomes for patients with multimorbidity.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Aoki T, Matsushima M. Treatment burden in complex versus simple multimorbidity: nationwide cross-sectional study in Japan. Fam Pract. 2026. PMID: 41920962. doi:10.1093/fampra/cmag016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。